TFRC and neoplasm: CD133 (cluster of differentiation 133), the pentaspan stem cell marker and a marker of tumor-initiating cells in a number of human cancers, can also inhibit iron intracellular uptake by interacting with TfR-1 and implicating in its endocytosis, thus participating in iron metabolism [9].